Healthcare - Biotechnology - NASDAQ - US
$ 3.64
0.276 %
$ 690 M
Market Cap
-8.47
P/E
INCOME STATEMENT
18.1 M
REVENUE
-78.1 M
OPERATING INCOME
-72.8 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Arbutus Biopharma Corporation
| Revenue | 18.1 M |
| Cost Of Revenue | 73.7 M |
| Gross Profit | -55.6 M |
| Operating Expenses | 22.5 M |
| Operating Income | -78.1 M |
| Other Expenses | -5.25 M |
| Net Income | -72.8 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | Dec-2005 | Dec-2004 | Dec-2003 | Dec-2002 | Dec-2001 | Dec-2000 | Dec-1999 | Dec-1998 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||||||||||||||||
| Revenue | 18.1 | 39.0 | 11.0 | 6.9 | 6.0 | 5.9 | 10.7 | 1.5 | 24.9 | 15.0 | 15.5 | 14.2 | 16.3 | 21.4 | 13.8 | 9.6 | 15.9 | 13.6 | 13.3 | 12.2 | 2.7 | 5.1 | 3.5 | 1.8 | 1.1 | 1.2 |
| GROSS PROFIT | ||||||||||||||||||||||||||
| Cost Of Revenue | 73.7 | 1.4 | 1.8 | 47.5 | 57.6 | 57.9 | 62.7 | 61.3 | 51.5 | 38.7 | 21.5 | 18.1 | 19.5 | 22.1 | 17.0 | 13.2 | 0 | 6.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | (55.6) | 37.6 | 9.2 | (40.6) | (51.6) | (52.0) | (52.0) | (59.8) | (26.6) | (23.7) | (6.0) | (3.9) | (3.2) | (0.8) | (3.2) | (3.6) | 15.9 | 7.4 | 13.3 | 12.2 | 2.7 | 5.1 | 3.5 | 1.8 | 1.1 | 1.2 |
| OPERATING INCOME | ||||||||||||||||||||||||||
| Operating Expenses | 22.5 | 102.2 | 82.6 | 64.2 | 77.4 | 76.1 | 80.8 | 101.8 | 78.5 | 47.9 | 27.6 | (19.5) | 7.1 | 11.7 | 5.9 | 4.7 | 13.3 | 9.1 | 14.4 | 35.6 | 37.4 | 32.8 | 19.9 | 11.0 | 9.3 | 10.0 |
| Selling, General and Administrative Expenses | 22.5 | 17.8 | 17.1 | 14.7 | 17.7 | 16.0 | 16.1 | 39.4 | 26.4 | 8.7 | 5.5 | 26.9 | 6.2 | 4.8 | 4.0 | 3.6 | 4.4 | 3.9 | 3.8 | 7.8 | 6.8 | 5.5 | 3.1 | 2.3 | 1.6 | 1.3 |
| Research and Development Expenses | 73.7 | 84.4 | 65.5 | 47.5 | 57.6 | 57.9 | 62.7 | 61.3 | 51.5 | 38.7 | 21.5 | 18.1 | 0 | 22 133 983.0 | 0 | 0 | 8.4 | 4.5 | 8.8 | 22.3 | 23.7 | 21.6 | 12.8 | 8.7 | 7.7 | 8.7 |
| Operating Income | (78.1) | (65.5) | (73.5) | (57.8) | (144.1) | (89.8) | (110.9) | (491.6) | (102.3) | (33.0) | (12.2) | (13.0) | (10.3) | (12.5) | (9.1) | (10.9) | 2.6 | (1.7) | (6.0) | (27.6) | (34.6) | (27.7) | (16.4) | (9.2) | (8.2) | (8.8) |
| PRE-TAX INCOME | ||||||||||||||||||||||||||
| Interest Income Expense | 0.5 | 1.7 | 2.9 | 4.0 | 2.1 | 0.2 | 0.3 | 0 | 0 | 0 | 0 | 47 K | 76.9 K | 0 | 0 | 0 | 0 | 1.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 5.3 | 0.4 | (2.7) | (5.9) | (22.5) | 28.4 | 2.2 | 2.5 | 25.0 | (5.4) | (1.9) | 42.6 | 0.6 | (5.6) | (0.5) | (0.8) | (5.2) | 19.8 | (6.5) | (4.0) | 0 | 0 | 0.5 | 0 | 0 | 0 |
| Pre-Tax Income | (72.8) | (65.0) | (76.2) | (63.7) | (166.4) | (61.4) | (108.7) | (489.1) | (77.3) | (38.7) | (14.1) | 29.9 | (9.9) | (12.5) | (9.5) | (11.7) | (2.6) | 18.1 | (7.7) | (29.8) | 0 | 0 | (16.0) | 0 | 0 | 0 |
| NET INCOME | ||||||||||||||||||||||||||
| Tax Provision | 0 | 4.4 | 1.1 | 1.5 | (12.7) | (4.3) | (24.3) | (105.0) | (16.2) | 100 K | 1.9 | 3.7 | (0.6) | 99.8 K | 0.3 | 3.4 | 0.000001 | 2.31 K | 0.4 | 8.9 | (0.5) | (0.9) | (2.3) | 0.000001 | 0.402 | 0.0343 |
| Net Income | (72.8) | (69.5) | (77.4) | (65.2) | (153.7) | (57.1) | (84.4) | (384.1) | (61.1) | (38.8) | (14.1) | 29.9 | (9.7) | (12.4) | (9.3) | (11.7) | (2.6) | 18.1 | (8.1) | (28.0) | (34.1) | (26.8) | (14.0) | (9.2) | (8.2) | (8.8) |
| EPS | 0.44 | 0.46 | 0.73 | 0.86 | 2.69 | 1.03 | 1.54 | 7.24 | 1.34 | 1.8 | 0.92 | 2.16 | 0.86 | 1.2 | 0.9 | 1.44 | 0.54 | 4.68 | 1.04 | 3.64 | 4.78 | 4.08 | 2.76 | 1.87 | 2.9 | 4.05 |